Among other health stock winners Wednesday were Merck (MRK), up 2.1% to $44.51; Pfizer (PFE), 1.7% higher to $26.35; GlaxoSmithKline (GSK), gaining 2.3% to $53.99; Par Pharmaceutical (PRX), up 3.3% to $23.10; Pharmion (PHRM), rising 4.4% to $26.86; and Omrix Biopharmaceuticals (OMRI), up 5% to $31.76.Among the losers were Novavax (NVAX), falling 5.1% to $3.89; Dynavax Technologies (DVAX), down 4.5% to $8.77; Somaxon Pharmaceuticals (SOMX), 3.7% lower to $13.67; Cubist Pharmaceuticals (CBST), off 4.2% to $17.35; and Catalyst Pharmaceutical (CPRX), sinking 9.9% to $4.35.
Wednesday's Health Winners and Losers
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts